Clinical Trial Update: Treating Heart Failure With hiPSC-CMs [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update is reported for treating heart failure using hiPSC-derived cardiomyocytes, spanning Phase 1 and Phase 2, with an unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• hiPSC-derived cardiomyocytes

Snippet

Sponsor: HELP Therapeutics Co., Ltd. | Conditions: Heart Failure | Phase 1, Phase 2 | Status: UNKNOWN